Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

May 11, 2027

Study Completion Date

May 11, 2028

Conditions
Oncogene-addicted Non Small Cell Lung CancerEGFR MutationALK Fusion-positive Solid or CNS TumorsROS1 Fusion PositiveRET Fusion PositiveERBB2 Mutation-Related TumorsNTRK1 Fusion PositiveNTRK2 Fusion PositiveNTRK3 Fusion PositiveNRG1 FusionBRAF V600 MutationKRAS G12C MutationMET Exon 14 Skipping Mutation
All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER